MADISON, N.J., Sept. 8, 2011 /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the Morgan Stanley Global Healthcare Conference in New York City. The presentation is scheduled for Tuesday, September 13, 2011 at 10:55 a.m. Eastern Time.
The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://www.corporate-ir.net/ireye/confLobby.zhtml?ticker=DGX&item_id=4185947 and to the public on www.QuestDiagnostics.com/investor. In addition, the archived webcast will be available starting one hour after the conclusion of the live event and will remain available until October 13, 2011.
Quest Diagnostics is the world's leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at www.QuestDiagnostics.com.
Kathleen Valentine (Investors):
Wendy Bost (Media):
SOURCE Quest Diagnostics